ALK's house dust mite pill wins EU nod


Sign up online today & collaborate

or click here to find out more

ALK's house dust mite pill wins EU nod

Date: 01/09/2015

Danish drugmaker ALK has garnered European approval for its house dust mite pill designed to help alleviate related allergic rhinitis and allergic asthma.

The house dust mite (HDM) sublingual allergy immunotherapy (SLIT) has been cleared for use in adult patients who continue to suffer from allergic rhinitis despite symptom-relieving medication, or when allergic asthma is not well controlled by inhaled corticosteroids.

For more click here

Source: PharmaTimes

© Catalyst Innovation Portal 2019